RXCELERATE LIMITED
Summary
RXCELERATE LIMITED was set up on Wednesday, November 7, 2012. Their current partial address is THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS and the company status is Active.
Credit Score
Latest Accounts Filed:
30/11/2022
Next Set of Accounts Due:
31/08/2024
Company Vitals
Company Name:
RXCELERATE LIMITED
Time in Business:
11 years
Company Number:
08284658
Current Status:
Active
Company Category:
Private Limited Company
Country of Origin:
United Kingdom
Principal Activity:
[72110] - Research and experimental development on biotechnology
Registered Address:
THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS
BABRAHAM
CAMBRIDGE
ENGLAND
CB22 3FH
Previous Names:
TCP BIOTECH LIMITED
Filing History
Submission | Date | Type |
---|---|---|
Resolution | 2024-03-11 | RESOLUTIONS |
Capital allotment shares | 2024-03-05 | SH01 |
Appoint person director company with name date | 2024-02-27 | AP01 |
Confirmation statement with no updates | 2023-11-21 | CS01 |
Accounts with accounts type group | 2023-08-11 | AA |
Change person director company with change date | 2023-07-12 | CH01 |
Mortgage satisfy charge full | 2022-12-06 | MR04 |
Confirmation statement with no updates | 2022-11-09 | CS01 |
Accounts with accounts type group | 2022-06-07 | AA |
Appoint person director company with name date | 2022-01-07 | AP01 |
Confirmation statement with no updates | 2021-11-16 | CS01 |
Accounts with accounts type group | 2021-07-14 | AA |
Confirmation statement with no updates | 2020-11-12 | CS01 |
Change registered office address company with date old address new address | 2020-10-19 | AD01 |
Accounts with accounts type group | 2020-10-12 | AA |
Change registered office address company with date old address new address | 2020-08-15 | AD01 |
Mortgage create with deed with charge number charge creation date | 2020-06-25 | MR01 |
Confirmation statement with updates | 2019-11-20 | CS01 |
Notification of a person with significant control | 2019-11-20 | PSC02 |
Accounts with accounts type group | 2019-09-05 | AA |